“Clinical outcomes and pathogenetic mechanisms of adjunctive ribonucleic acid therapy in adult patients with measles during the period of increased incidence in 2025–2026”, ІХ, no. 3, pp. 13–26, Sep. 2026, doi: 10.11603/1681-2727.2026.3.16753.